8/8/2019 Drugs and Nervous System http://slidepdf.com/reader/full/drugs-and-nervous-system 1/30 NERVOUS SYSTEM Drugs and Poisons Chem 377 1 Drugs and The Nervous System
8/8/2019 Drugs and Nervous System
http://slidepdf.com/reader/full/drugs-and-nervous-system 1/30
NERVOUS SYSTEM Drugs and Poisons
Chem 377
1
Drugs and
The Nervous System
8/8/2019 Drugs and Nervous System
http://slidepdf.com/reader/full/drugs-and-nervous-system 2/30
NERVOUS SYSTEM Drugs and Poisons
Chem 377
2
stimulus response
cells & tissues
muscle cells
secretory cells
information storage
integration
by sensory cells (nerves)
(receptors) (effectors)
8/8/2019 Drugs and Nervous System
http://slidepdf.com/reader/full/drugs-and-nervous-system 3/30
NERVOUS SYSTEM Drugs and Poisons
Chem 377
3
axon
dendrite
cell body
preganglionic
synapse
postganglionic
synapse
neuroeffector
cell CNS
action potential (AP)
8/8/2019 Drugs and Nervous System
http://slidepdf.com/reader/full/drugs-and-nervous-system 4/30
NERVOUS SYSTEM Drugs and Poisons
Chem 377
4
8/8/2019 Drugs and Nervous System
http://slidepdf.com/reader/full/drugs-and-nervous-system 5/30
NERVOUS SYSTEM Drugs and Poisons
Chem 377
5
Schwanncell
unmyelinated nerve cell
myelinated nerve cell
Schwann cells in the CNS
Oligodendrocite cells in the PNS
saltatory conductance
node to node
node ofRanvier
8/8/2019 Drugs and Nervous System
http://slidepdf.com/reader/full/drugs-and-nervous-system 6/30
NERVOUS SYSTEM Drugs and Poisons
Chem 377
6myelinated nerve cell (Schwann cell)
8/8/2019 Drugs and Nervous System
http://slidepdf.com/reader/full/drugs-and-nervous-system 7/30
NERVOUS SYSTEM Drugs and Poisons
Chem 377
7
potential
in
millivolts
0
-70resting state
Na+ gate
opening
K+ gate
opening
Na+ /K+ pump
operating
Action Potential
The action potential is
propagated down the
length of a nerve cell.
time
Generation of the Action Potential
intracellular environment of the nerve
cell membrane
cell membrane
[Na+] [K+]
This ion inbalance is maintained by the Na+-K+ ATPase pump.
The intracellular side of the membrane is ~70mv lower in potentialthat the extracellular side.
-70mv
extracellular environment
8/8/2019 Drugs and Nervous System
http://slidepdf.com/reader/full/drugs-and-nervous-system 8/30
NERVOUS SYSTEM Drugs and Poisons
Chem 377
8
CH3
RO
CH3
OH
O
The group of activecompounds are knownas the cardiac glycosides.
If R= carbohydrate thenDigitoxin or Digitalin
Digitoxigenin R=H
The Digitalis Alkaloids
Toxins Affecting the Na+-K+ Pump
Sources: foxglove, purple foxglove, fairy gloves
LD50(guinea pigs, cats): 60.0, 0.18 mg;kg
The therapeutic dose is close to the toxic dose.
Sy mptoms: anorexia, nausea, salivation, vomiting,
headache, drowsiness, disorientation, delirium,
hallucinations; can be fatal.
Uses: cardiac stimulant (Cry stodigin®, Lanoxin®,
Digibind®)
pharmacokinetics: half-life 1.5 days
60% excreted through the kidneys, 30% by the liver
inotropic agent - causes more efficient contraction of the heart
used to treat congestive heart failure
8/8/2019 Drugs and Nervous System
http://slidepdf.com/reader/full/drugs-and-nervous-system 9/30
NERVOUS SYSTEM Drugs and Poisons
Chem 377
9
Ca2+
Na+
C(CH2)3NCH2CH2
OCH3
OCH3
CH3O
CH3O
CN
CH(CH3)2
initial dose - 5-10 mg
LD50 (mice, rats): 16, 8 mg/kg(i.v .)
Calan®, Isotopin®, Cordilox®,Vasolan®
verapamil
NCH3 CH3
CH3OC COCH3
NO2
O
H
O
initial dose - 10 mg
LD50 (mice, rats): 494, 1022 mg/kg (oral)
4.2, 15.5 mg/kg (i.v.)
Adalat®, Procardia®
nifedipine
Calcium channel blockers
intracellular environment of the nerve
cell membrane
cell membrane
extracellular environment
[Ca2+]
Ca2+
ATPaseNa+/Ca2+
Exchange
gates Ca2+
Na+
8/8/2019 Drugs and Nervous System
http://slidepdf.com/reader/full/drugs-and-nervous-system 10/30
NERVOUS SYSTEM Drugs and Poisons
Chem 377
10
Multiple Sclerosis
myelin degeneration (demyelination)
multiple sclerotic plaques
presence of antibodies and killer T-cells of immune system
Incidence
U.S. - 300,000 (could be classified as an orphan condition)
prevalent in temperate climates
mainly females, ages 20-45 years
usually chronic; sometimes acute
Symptoms
muscle weakness
lack of coordination
difficulty in vision
spasticity
vertigo
facial numbness
tremor
emotional lability
8/8/2019 Drugs and Nervous System
http://slidepdf.com/reader/full/drugs-and-nervous-system 11/30
NERVOUS SYSTEM Drugs and Poisons
Chem 377
11
Toxins affecting the action potential
Na+
-channel blockers
NN
OOH2N
HOHO
OH
CH2OH
HO
H
H
Sources: flora inhabiting puffer fish (roe, liv er,
skin), some newts, octopi and frogs,
gobys, the California salamander
LD50 (mice): 10 mg/kg (i.p.)
Sy mptoms: spreading paralysis
Antidote: none (60% fatality )
Uses: Puffer fish is a Japanese delicacy .
A chef must be licensed to prepare puffer
fish. Some thrill seekers wil l prepare it
improperly to see how far they can go.
tetrodotoxin
+
“...that voodoo, that you do, to me...”
8/8/2019 Drugs and Nervous System
http://slidepdf.com/reader/full/drugs-and-nervous-system 12/30
NERVOUS SYSTEM Drugs and Poisons
Chem 377
12
ON
O
N N
N
H2N
NH2
H
H
OHOH
H2N
H
saxitoxin
+
+
Sources: dinoflagellates(protozoa) of the
genusGinoyaulax - the "red tide"-
shellfish feed upon these planktonic algae
and become s torage depots for the toxin
LD50(mice) : 263g/kg(oral)
(humans) about 1-4 mg total
Sy mptoms: paraly sis
Antidote: none
HN
CO2H
CH3
HO2C
HO2C
H3Cdomoic acid
binds to kainate receptors
Chondra armata
SXT
paralytic shellfish poisoning
8/8/2019 Drugs and Nervous System
http://slidepdf.com/reader/full/drugs-and-nervous-system 13/30
NERVOUS SYSTEM Drugs and Poisons
Chem 377
13
N
CH3CH2
OCH3
OCH3
CH3OCH2
HO
OHOCH3
OC
OH
OCCH3
O
O
Sources: Aconitum napellus, Ranunculaceae
LD50 (mice): 1 mg/kg (oral)
Sy mptoms: heart arrhythmia
Use: arrow poison
aconitine
8/8/2019 Drugs and Nervous System
http://slidepdf.com/reader/full/drugs-and-nervous-system 14/30
NERVOUS SYSTEM Drugs and Poisons
Chem 377
14
H3C OC
O
NN
CH3
H3C
CH3
H
O
O
H3C
HO
HO
Source: skin of Columbian
frog Phyllobatus
aurotaenia
LD50(mice): 1 mg/kg (i.v.)
Use: arrow poison
batrachotoxin
N CH2CH
OHH
CHC CH
CHCCHCH
histrionicotoxins
N
C H3
C H2C H3
H
pumiliotoxin C
NHOCH2C H2
C H2C H C H C C H
gephyrotoxin
C H3
OH
C H C H
C H3
C H2C HC H3CHCHC
OH C H3
OH pulmiliotoxin B
8/8/2019 Drugs and Nervous System
http://slidepdf.com/reader/full/drugs-and-nervous-system 15/30
NERVOUS SYSTEM Drugs and Poisons
Chem 377
15
Scorpion toxins
Sea anemones
Predatory cone snails
conotoxins
30-78 amino acid polypeptides
persistent activation of Na+channels
8/8/2019 Drugs and Nervous System
http://slidepdf.com/reader/full/drugs-and-nervous-system 16/30
NERVOUS SYSTEM Drugs and Poisons
Chem 377
16
Mass of a large sensory neuron 10-6 gram
Diameter of a neuron4 microns to 100 microns
(motor neuron in cord)
15 feetLength of a giraffe primary afferentaxon (toe to neck)
Typical number of sodium pumps1,000 pumps/square micron ofmembrane surface
Total number of sodium pumps for asmall neuron 1 million
Density of sodium channels300 per square micron in the giantsquid axon
Number of voltage-gated sodium
channels in unmyelinated axon
100-200 per square micron
Number of voltage-gated sodiumchannels at each node
1000-2000 per square micron
Number of voltage-gated sodiumchannels between nodes
25 per square micron
Neuron Factoids
8/8/2019 Drugs and Nervous System
http://slidepdf.com/reader/full/drugs-and-nervous-system 17/30
NERVOUS SYSTEM Drugs and Poisons
Chem 377
17
Number of synapses for a “typical”
neuron1,000 to 10,000
Thickness of neuronal membrane 5 nanometers
Conduction velocity of action potential 0.6-120 m/s (1.2-250 miles/hr)
Typical synaptic cleft distance 20-40 nanometers across
Diameter of synaptic vesicle 50 nanometers
Number of neurotransmittermolecules in one synaptic vesicle
5,000
Axonal transport rate Slow 0.2-4mm/day
(actin, tubulin)
Intermediate 15-50mm/day
(mitochondrial protein)
Fast 200-400mm/day
(peptides, glycolipids)
Neuron Factoids
8/8/2019 Drugs and Nervous System
http://slidepdf.com/reader/full/drugs-and-nervous-system 18/30
NERVOUS SYSTEM Drugs and Poisons
Chem 377
18
From http://www.dreisen.com/anatomy_of_a_neuron.htm
8/8/2019 Drugs and Nervous System
http://slidepdf.com/reader/full/drugs-and-nervous-system 19/30
NERVOUS SYSTEM Drugs and Poisons
Chem 377
19
Autonomicinvoluntary
v isceral motor andsensory systems, smoothmuscle, glands
Somatic
Voluntary
reflex as well asconscious action,muscles
CNS
(central
nervous
system)
PNS
(peripheral
nervous
system)anatomical
distinctions
functional
distinctions
Parasympathetic
vegetative
Sympatheticfight or flight
chemical distinctions
8/8/2019 Drugs and Nervous System
http://slidepdf.com/reader/full/drugs-and-nervous-system 20/30
NERVOUS SYSTEM Drugs and Poisons
Chem 377
20
SNS Effects PNS Effects
Organ or Tissue
The Autonomic NervousSystem
EYES
HEART RATE
BLOOD PRESSURE
BLOOD GLUCOSE
BRONCHIOLES
RBC PRODUCTION
SWEAT GLANDS
SALIVA
PERISTALSIS
DIGESTION
Dilated
Increased
Dilated
Increased
Elevated
Increased
Stimulated
Thick Secretion
Inhibited
Inhibited
Contracted
Decreased
Constricted
Decreased
Normal
Normal
Normal
Watery Secretion
Normal
Stimulated
8/8/2019 Drugs and Nervous System
http://slidepdf.com/reader/full/drugs-and-nervous-system 21/30
NERVOUS SYSTEM Drugs and Poisons
Chem 377
21
receptors
synaptic vesicles
postsynaptic
membrane
presynaptic
membrane
The Synapse (synaptic cleft)
Action Potential
dendrite axon
50-200 A
Action Potential
CH3
CH3COCH2CH2N CH3
CH3
O
acetylcholine (Ach)
HO
HO
CHCH2NH(2)
OH CH3
norepinephrine (NE) epinephrine - E
HO
HO
C H2C H2NH2
dopamine (DA)NH
CH2CH2NH2HO
serotonin (5-hydroxy tryptamine - 5-HT)
8/8/2019 Drugs and Nervous System
http://slidepdf.com/reader/full/drugs-and-nervous-system 22/30
NERVOUS SYSTEM Drugs and Poisons
Chem 377
22
postsy naptic
receptor
SYNAPTIC CLEFT
ACTION POTENTIAL
ACTION POTENTIAL
presynaptic
receptor
sy naptic
vesicles
12
34
5
6
8
7c
7b
7a
1 biosynthesis of NT 6 the NT-receptor complex triggersgeneration of the AP
2 storage of NTs in synaptic vesicles 7a NT dissociates from receptor andeither
diffuses away,3 arrival of AP trigger fus ion of ves icle
with synaptic membrane and7b is enzymatically broken down, or
4 release of neurotransmitter 7c taken back up into the presynapticending.
5 NT diffuses to postsynaptic membranewhere it combines with a receptor.
8 The NT may also bind withpresynaptic receptors as a regulatorydevice for NT release.
8/8/2019 Drugs and Nervous System
http://slidepdf.com/reader/full/drugs-and-nervous-system 23/30
NERVOUS SYSTEM Drugs and Poisons
Chem 377
23
From http://www.dreisen.com/anatomy_of_a_neuron.htm
8/8/2019 Drugs and Nervous System
http://slidepdf.com/reader/full/drugs-and-nervous-system 24/30
NERVOUS SYSTEM Drugs and Poisons
Chem 377
24
AP
axon
synapticvesicles
presynaptic membrane
postsynaptic membrane
synapse
postsynaptic receptorsdirect ion channels
8/8/2019 Drugs and Nervous System
http://slidepdf.com/reader/full/drugs-and-nervous-system 25/30
NERVOUS SYSTEM Drugs and Poisons
Chem 377
25
CH3C SCoA
O
HOCH2CH2N CH3
CH3
CH3
CH3COCH2CH2N CH3
O CH3
CH3acetylcholine
esterase (Achase)
+
choline acetyl
transferase (CAT)
acetyl coenzyme A choline acetylcholine
H3NCHCOO-+
CH2CH2CH2NHC=NH2+
NH2arginine
NADPH
O2
nitric oxide
synthase
H3NCHCOO-+
CH2CH
2CH
2NHC=O
NH2
+ NADP+
N O
+
citrulline
N
N
N
NH
H3C O
O
H3C
SO
O
N
N
CH3
sildenafilVIAGRA®
PDE-5 inhibitor
8/8/2019 Drugs and Nervous System
http://slidepdf.com/reader/full/drugs-and-nervous-system 26/30
NERVOUS SYSTEM Drugs and Poisons
Chem 377
26
CH2CHCOH
O
NH2
Dietary Protein
L-Phenylalaninean essential amino acid
HO CH2CHCOH
O
NH2
L-Tyrosinea nonessential amino acid
HO
HO
CH2CHCOH
O
NH2Dihydroxyphenylalanine
(L-DOPA)
HO
HO
CH2CH2NH2
Dopamine (DA)
HO
HO
CHCH2NH2
HONorepinephrine (N E)
HO
HO
CHCH2NHCH3
HO
phenylalanine
hydroxylase
tyrosine
hydroxylase
dopamine b -
hydroxylase
monoamine oxidase
(MAO)
catecholamine-O-
methyl transferase
(COMT)
L-aromatic amino acid
decarboxylase
DOPA-decarboxylase
phenylethanolamine-N-
methyl transferase
Synthesis ofCatecholamines
8/8/2019 Drugs and Nervous System
http://slidepdf.com/reader/full/drugs-and-nervous-system 27/30
NERVOUS SYSTEM Drugs and Poisons
Chem 377
27
parasympathetic system sympathetic system
nicotinic
receptors
muscarinic
receptors
nicotinic
receptors
acetylcholine
acetylcholine
acetylcholine
norepinephrine
adrenergic
receptors
CHOLINERGIC
CHOLINERGIC
ADRENERGIC
8/8/2019 Drugs and Nervous System
http://slidepdf.com/reader/full/drugs-and-nervous-system 28/30
NERVOUS SYSTEM Drugs and Poisons
Chem 377
28axonal synaptic area
8/8/2019 Drugs and Nervous System
http://slidepdf.com/reader/full/drugs-and-nervous-system 29/30
NERVOUS SYSTEM Drugs and Poisons
Chem 377
29
INACTIVE
protein kinase
cAMP cAMP cAMP
catalytically ACTIVE
protein kinase
cAMP-regulatory
subunit complexes
The cAMP Stimulated Activation of a Protein Kinase
ex tracellular intracellular
Rs
Ri
stimulatory
receptors
inhibitory
receptors
Gs protein
Gi protein
adenylate cyclase
intracellular
Rs
Gs protein
adenylate cyclase
extracellular Neurohormone
receptor
complex
ATP
cAMP + PPi
G- Protein Complex and Generation of Cyclic AMP (cAMP)
8/8/2019 Drugs and Nervous System
http://slidepdf.com/reader/full/drugs-and-nervous-system 30/30
NERVOUS SYSTEM Drugs and Poisons
Chem 377
30
cAMP cAMP
phosphodiesterase
AMP AMP
Reassociation of Inactive Complex
after Phosphodiesterase Cleavage
N
N N
N
NH2
OHO-P-O-P-O-PO
O O O
N
N N
N
NH2
O
N
N N
N
NH2
O
OHOH
O
O
P
O OH
O
O
HOPO
OHOH
O
O
(AMP)
5'-Adenosine
Monophosphate (cAMP)
Cyclic Adenosine
3',5'-monophosphate
O O- - -
Adenosine
Triphosphate
ATP
- i+ PP
adenylate
cyclase
-
phosphodiesterase
H2O